| 四川科伦博泰生物医药股份有限公司 - H股, 06990.HK - 综合现金流量表 |
2022-12 |
2021-12 |
| 经营活动之现金流量 |
-270,847 |
-485,942 |
| 投资回报及融资费用之现金流量 |
-2,927 |
-39,989 |
| 已收利息 |
0 |
0 |
| 已付利息 |
-2,927 |
-39,989 |
| 已收股息 |
0 |
0 |
| 已付股息 |
0 |
0 |
| 其他 |
0 |
0 |
| 退回/(已缴)税项 |
0 |
0 |
| 投资活动之现金流量 |
-32,150 |
-94,384 |
| 增添固定资产 |
-33,659 |
-94,083 |
| 出售固定资产 |
6,329 |
0 |
| 投资增加 |
-370,000 |
-140,000 |
| 投资减少 |
370,513 |
140,359 |
| 与关联人士之现金流量 |
248,000 |
185,484 |
| 其他 |
-253,333 |
-186,144 |
| 融资活动前之现金流量 |
-305,924 |
-620,315 |
| 融资活动之现金流量 |
316,379 |
687,305 |
| 新增贷款 |
115,000 |
30,000 |
| 偿还贷款 |
-46,621 |
-61,990 |
| 定息/债项工具融资 |
0 |
511,783 |
| 偿还定息/债项工具 |
0 |
0 |
| 股本融资 |
0 |
22,028 |
| 与关联人士之现金流量 |
248,000 |
185,484 |
| 其他 |
0 |
0 |
| 现金及等同现金之增加/(减少) |
10,455 |
66,990 |
| 年初之现金及现金等同项目 |
81,793 |
16,189 |
| 外汇兑换率变动之影响/(其他) |
712 |
-1,386 |
| 年终之现金及现金等同项目 |
92,960 |
81,793 |
| 货币 |
人民币 |
人民币 |
| 单位 |
| 核数师意见 |
0 |
0 |
说明：1代表无保留意见；2代表保留意见；3代表修改意见
|
We've noticed you're using an ad blocker
We spend millions of dollars each year so you can access, for FREE, the highest quality real-time quotes and charts. This is made possible only thanks to the advertising on our site.
To continue using 88iv.com, please allow this domain on your ad blocker.
We are thanksful for your decisive action.
This notice will be shown again every hour.
Close This Window
|